⌘K
Loading ticker…
As of 2026-08-24, ENDRA Life Sciences Inc. Common Stock (NDRA) has a 3-month relative strength percentile of 23 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.1%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
NDRA appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $13K notional.
Held by 1 ETFs · $13K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $13K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NDRA Jan avg: -22.81% median: -19.64% win: 0% σ: 20.54% n: 4 2022-04-12 → 2026-07-31 | NDRA Feb avg: 0.79% median: 1.97% win: 50% σ: 8.83% n: 4 2022-04-12 → 2026-07-31 | NDRA Mar avg: -20.69% median: -23.30% win: 25% σ: 28.81% n: 4 2022-04-12 → 2026-07-31 | NDRA Apr avg: -9.56% median: -17.78% win: 40% σ: 37.36% n: 5 2022-04-12 → 2026-07-31 | NDRA May avg: -11.14% median: -8.13% win: 20% σ: 20.76% n: 5 2022-04-12 → 2026-07-31 | NDRA Jun avg: -13.12% median: -3.09% win: 40% σ: 28.64% n: 5 2022-04-12 → 2026-07-31 | NDRA Jul avg: 5.17% median: -11.43% win: 40% σ: 29.00% n: 5 2022-04-12 → 2026-07-31 | NDRA Aug avg: -28.08% median: -14.11% win: 25% σ: 43.09% n: 4 2022-04-12 → 2026-07-31 (current) | NDRA Sep avg: -4.02% median: -0.11% win: 50% σ: 32.86% n: 4 2022-04-12 → 2026-07-31 | NDRA Oct avg: -3.35% median: -6.84% win: 25% σ: 21.10% n: 4 2022-04-12 → 2026-07-31 | NDRA Nov avg: -11.15% median: -11.02% win: 50% σ: 21.72% n: 4 2022-04-12 → 2026-07-31 | NDRA Dec avg: 28.62% median: 12.11% win: 75% σ: 59.12% n: 4 2022-04-12 → 2026-07-31 |